- Home
- DTSQ vs ANVS Comparison
DTSQ vs ANVS Comparison
Compare DTSQ & ANVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DTSQ
- ANVS
- Stock Information
- Founded
- DTSQ 2022
- ANVS 2008
- Country
- DTSQ United States
- ANVS United States
- Employees
- DTSQ N/A
- ANVS N/A
- Industry
- DTSQ
- ANVS Biotechnology: Pharmaceutical Preparations
- Sector
- DTSQ
- ANVS Health Care
- Exchange
- DTSQ NYSE
- ANVS Nasdaq
- Market Cap
- DTSQ 89.8M
- ANVS 31.2M
- IPO Year
- DTSQ 2024
- ANVS 2020
- Fundamental
- Price
- DTSQ $10.21
- ANVS $1.65
- Analyst Decision
- DTSQ
- ANVS Strong Buy
- Analyst Count
- DTSQ 0
- ANVS 5
- Target Price
- DTSQ N/A
- ANVS $37.00
- AVG Volume (30 Days)
- DTSQ 42.9K
- ANVS 435.2K
- Earning Date
- DTSQ 01-01-0001
- ANVS 03-31-2025
- Dividend Yield
- DTSQ N/A
- ANVS N/A
- EPS Growth
- DTSQ N/A
- ANVS N/A
- EPS
- DTSQ 0.17
- ANVS N/A
- Revenue
- DTSQ N/A
- ANVS N/A
- Revenue This Year
- DTSQ N/A
- ANVS N/A
- Revenue Next Year
- DTSQ N/A
- ANVS N/A
- P/E Ratio
- DTSQ $61.38
- ANVS N/A
- Revenue Growth
- DTSQ N/A
- ANVS N/A
- 52 Week Low
- DTSQ $9.96
- ANVS $1.53
- 52 Week High
- DTSQ $10.37
- ANVS $20.00
- Technical
- Relative Strength Index (RSI)
- DTSQ N/A
- ANVS 24.29
- Support Level
- DTSQ N/A
- ANVS $1.53
- Resistance Level
- DTSQ N/A
- ANVS $1.77
- Average True Range (ATR)
- DTSQ 0.00
- ANVS 0.16
- MACD
- DTSQ 0.00
- ANVS 0.09
- Stochastic Oscillator
- DTSQ 0.00
- ANVS 18.18
About DTSQ DT CLOUD STAR ACQUISITION CORP
DT Cloud Star Acquisition Corp is a blank check company.
About ANVS Annovis Bio Inc.
Annovis Bio Inc is a clinical-stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neurodegenerative diseases. The pipeline products of the company consists of: Buntanetap for chronic neurodegeneration - including AD and PD; ANVS405 for acute neurodegeneration; and ANVS301 for advanced AD.